4don MSN
Seeing thyroid cancer in a new light: When AI meets label-free imaging in the operating room
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
News-Medical.Net on MSN
AI-powered optical imaging helps surgeons identify thyroid cancer in real time
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.
We know we should all be wearing sunscreen. But how can you ensure the one you are using is reliable? We spoke to experts to ...
New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...
Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, and Unicancer, the leading French network dedicated exclusively to cancer care and research ...
StockStory.org on MSN
Branded pharmaceuticals stocks Q3 results: Benchmarking Royalty Pharma (NASDAQ:RPRX)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
TRT Australia now offers telehealth services to prioritise depression treatment for men with low testosterone. The clinic ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
(Yicai) Jan. 8 -- [Editor's note] With the implementation of international environmental, social, and governance standards, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results